XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.4
Equity
3 Months Ended
Nov. 28, 2024
Equity [Abstract]  
Equity
Equity

Common Stock Repurchases

Our Board of Directors has authorized the discretionary repurchase of up to $10 billion of our outstanding common stock through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans. The repurchase authorization has no expiration date, does not obligate us
to acquire any common stock, and is subject to market conditions, restrictions applicable under our CHIPS Act direct funding agreements, and our ongoing determination of the best use of available cash. See “Item 1. Financial Statements – Notes to Consolidated Financial Statements – CHIPS Act Funding Agreements.” No shares were repurchased in the first quarter of 2025. Through November 28, 2024, we had repurchased an aggregate of $7.19 billion under the authorization. Amounts repurchased are included in treasury stock.

Dividends

In the first quarter of 2025, we declared and paid dividends of $0.115 per share. On December 18, 2024, our Board of Directors declared a quarterly dividend of $0.115 per share, payable in cash on January 15, 2025, to shareholders of record as of the close of business on December 30, 2024.

Accumulated Other Comprehensive Income (Loss)

Changes in accumulated other comprehensive income (loss) by component for the three months ended November 28, 2024 were as follows:
Gains (Losses) on Derivative InstrumentsUnrealized Gains (Losses) on InvestmentsPension Liability AdjustmentsCumulative Foreign Currency Translation AdjustmentTotal
As of August 29, 2024$(162)$(8)$39 $(3)$(134)
Other comprehensive income (loss) before reclassifications
(137)(2)— — (139)
Amount reclassified out of accumulated other comprehensive income (loss)
40 (1)— — 39 
Tax effects
12 — — 13 
Other comprehensive income (loss)(85)(2)— — (87)
As of November 28, 2024$(247)$(10)$39 $(3)$(221)